Cargando…
The impact of intravenous iron supplementation in elderly patients undergoing major surgery
BACKGROUND: Age and preoperative anaemia are risk factors for poor surgical outcome and blood transfusion. The aim of this study was to examine the effect of iron supplementation in iron-deficient (ID) elderly patients undergoing major surgery. METHOD: In this single-centre observational study, pati...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988356/ https://www.ncbi.nlm.nih.gov/pubmed/35392839 http://dx.doi.org/10.1186/s12877-022-02983-y |
_version_ | 1784682943261704192 |
---|---|
author | Blum, Lea Valeska Zierentz, Philipp Hof, Lotta Kloka, Jan Andreas Messroghli, Leila Zacharowski, Kai Meybohm, Patrick Choorapoikayil, Suma |
author_facet | Blum, Lea Valeska Zierentz, Philipp Hof, Lotta Kloka, Jan Andreas Messroghli, Leila Zacharowski, Kai Meybohm, Patrick Choorapoikayil, Suma |
author_sort | Blum, Lea Valeska |
collection | PubMed |
description | BACKGROUND: Age and preoperative anaemia are risk factors for poor surgical outcome and blood transfusion. The aim of this study was to examine the effect of iron supplementation in iron-deficient (ID) elderly patients undergoing major surgery. METHOD: In this single-centre observational study, patients ≥ 65 years undergoing major surgery were screened for anaemia and ID. Patients were assigned to the following groups: A(−) (no anaemia); A(−),ID(+),T(+) (no anaemia, iron-deficient, intravenous iron supplementation); A(+) (anaemia); and A(+),ID(+),T(+) (anaemia, iron-deficient, intravenous iron supplementation). RESULTS: Of 4,381 patients screened at the anaemia walk-in clinic, 2,381 (54%) patients were ≥ 65 years old and 2,191 cases were included in analysis. The ID prevalence was 63% in patients with haemoglobin (Hb) < 8 g/dl, 47.2% in patients with Hb from 8.0 to 8.9 g/dl, and 44.3% in patients with Hb from 9 to 9.9 g/dl. In severely anaemic patients, an Hb increase of 0.6 (0.4; 1.2) and 1.2 (0.7; 1.6) g/dl was detected with iron supplementation 6–10 and > 10 days before surgery, respectively. Hb increased by 0 (-0.1; 0) g/dl with iron supplementation 1–5 days before surgery, 0.2 (-0.1; 0.5) g/dl with iron supplementation 6–10 days before surgery, and 0.2 (-0.2; 1.1) g/dl with supplementation > 10 days before surgery (p < 0.001 for 1–5 vs. 6–10 days). Overall, 58% of A(+),ID(+),T(+) patients showed an Hb increase of > 0.5 g/dl. The number of transfused red blood cell units was significantly lower in patients supplemented with iron (0 (0; 3)) compared to non-treated anaemic patients (1 (0; 4)) (p = 0.03). Patients with iron supplementation > 6 days before surgery achieved mobility 2 days earlier than patients with iron supplementation < 6 days. CONCLUSIONS: Intravenous iron supplementation increases Hb level and thereby reduces blood transfusion rate in elderly surgical patients with ID anaemia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-022-02983-y. |
format | Online Article Text |
id | pubmed-8988356 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89883562022-04-08 The impact of intravenous iron supplementation in elderly patients undergoing major surgery Blum, Lea Valeska Zierentz, Philipp Hof, Lotta Kloka, Jan Andreas Messroghli, Leila Zacharowski, Kai Meybohm, Patrick Choorapoikayil, Suma BMC Geriatr Research BACKGROUND: Age and preoperative anaemia are risk factors for poor surgical outcome and blood transfusion. The aim of this study was to examine the effect of iron supplementation in iron-deficient (ID) elderly patients undergoing major surgery. METHOD: In this single-centre observational study, patients ≥ 65 years undergoing major surgery were screened for anaemia and ID. Patients were assigned to the following groups: A(−) (no anaemia); A(−),ID(+),T(+) (no anaemia, iron-deficient, intravenous iron supplementation); A(+) (anaemia); and A(+),ID(+),T(+) (anaemia, iron-deficient, intravenous iron supplementation). RESULTS: Of 4,381 patients screened at the anaemia walk-in clinic, 2,381 (54%) patients were ≥ 65 years old and 2,191 cases were included in analysis. The ID prevalence was 63% in patients with haemoglobin (Hb) < 8 g/dl, 47.2% in patients with Hb from 8.0 to 8.9 g/dl, and 44.3% in patients with Hb from 9 to 9.9 g/dl. In severely anaemic patients, an Hb increase of 0.6 (0.4; 1.2) and 1.2 (0.7; 1.6) g/dl was detected with iron supplementation 6–10 and > 10 days before surgery, respectively. Hb increased by 0 (-0.1; 0) g/dl with iron supplementation 1–5 days before surgery, 0.2 (-0.1; 0.5) g/dl with iron supplementation 6–10 days before surgery, and 0.2 (-0.2; 1.1) g/dl with supplementation > 10 days before surgery (p < 0.001 for 1–5 vs. 6–10 days). Overall, 58% of A(+),ID(+),T(+) patients showed an Hb increase of > 0.5 g/dl. The number of transfused red blood cell units was significantly lower in patients supplemented with iron (0 (0; 3)) compared to non-treated anaemic patients (1 (0; 4)) (p = 0.03). Patients with iron supplementation > 6 days before surgery achieved mobility 2 days earlier than patients with iron supplementation < 6 days. CONCLUSIONS: Intravenous iron supplementation increases Hb level and thereby reduces blood transfusion rate in elderly surgical patients with ID anaemia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-022-02983-y. BioMed Central 2022-04-07 /pmc/articles/PMC8988356/ /pubmed/35392839 http://dx.doi.org/10.1186/s12877-022-02983-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Blum, Lea Valeska Zierentz, Philipp Hof, Lotta Kloka, Jan Andreas Messroghli, Leila Zacharowski, Kai Meybohm, Patrick Choorapoikayil, Suma The impact of intravenous iron supplementation in elderly patients undergoing major surgery |
title | The impact of intravenous iron supplementation in elderly patients undergoing major surgery |
title_full | The impact of intravenous iron supplementation in elderly patients undergoing major surgery |
title_fullStr | The impact of intravenous iron supplementation in elderly patients undergoing major surgery |
title_full_unstemmed | The impact of intravenous iron supplementation in elderly patients undergoing major surgery |
title_short | The impact of intravenous iron supplementation in elderly patients undergoing major surgery |
title_sort | impact of intravenous iron supplementation in elderly patients undergoing major surgery |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988356/ https://www.ncbi.nlm.nih.gov/pubmed/35392839 http://dx.doi.org/10.1186/s12877-022-02983-y |
work_keys_str_mv | AT blumleavaleska theimpactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery AT zierentzphilipp theimpactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery AT hoflotta theimpactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery AT klokajanandreas theimpactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery AT messroghlileila theimpactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery AT zacharowskikai theimpactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery AT meybohmpatrick theimpactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery AT choorapoikayilsuma theimpactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery AT blumleavaleska impactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery AT zierentzphilipp impactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery AT hoflotta impactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery AT klokajanandreas impactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery AT messroghlileila impactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery AT zacharowskikai impactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery AT meybohmpatrick impactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery AT choorapoikayilsuma impactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery |